These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3298419)

  • 1. The effects of a 50% reduction of cis(z)-flupenthixol decanoate in chronic schizophrenic patients maintained on a high dose regime.
    Cookson IB
    Int Clin Psychopharmacol; 1987 Apr; 2(2):141-9. PubMed ID: 3298419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative double-blind study of flupenthixol decanoate and fluphenazine decanoate in the treatment of patients relapsing in a schizophrenic symptomatology.
    Wistedt B; Ranta J
    Acta Psychiatr Scand; 1983 Jun; 67(6):378-88. PubMed ID: 6349256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haloperidol decanoate and flupenthixol decanoate in schizophrenia. A long-term double-blind cross-over comparison.
    Eberhard G; Hellbom E
    Acta Psychiatr Scand; 1986 Sep; 74(3):255-62. PubMed ID: 3788652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Kong DS; Yeo SH
    Pharmatherapeutica; 1989; 5(6):371-9. PubMed ID: 2687894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trial of flupenthixol decanoate in chronic withdrawn schizophrenic patients.
    Vichaiya V
    J Med Assoc Thai; 1980 Apr; 63(4):205-9. PubMed ID: 6991627
    [No Abstract]   [Full Text] [Related]  

  • 6. Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out-patients.
    Knights A; Okasha MS; Salih MA; Hirsch SR
    Br J Psychiatry; 1979 Dec; 135():515-23. PubMed ID: 394794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind comparison of flupenthixol decanoate and fluphenazine decanoate in the treatment of chronic schizophrenia.
    Pinto R; Bannerjee A; Ghosh N
    Acta Psychiatr Scand; 1979 Oct; 60(4):313-22. PubMed ID: 390972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and social comparison of fluphenazine decanoate and flupenthixol decanoate in the community maintenance therapy of schizophrenia.
    Kelly HB; Freeman HL; Banning B; Schiff AA
    Int Pharmacopsychiatry; 1977; 12(1):54-64. PubMed ID: 406212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flupenthixol in chronic schizophrenic inpatients: a controlled comparison with haloperidol.
    Ehmann TS; Delva NJ; Beninger RJ
    J Clin Psychopharmacol; 1987 Jun; 7(3):173-5. PubMed ID: 3298328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flupenthixol decanoate (fluanxol depot) in the treatment of chronic schizophrenic patients.
    Haider I
    J Pak Med Assoc; 1985 Sep; 35(9):286-9. PubMed ID: 3934417
    [No Abstract]   [Full Text] [Related]  

  • 11. Double-blind comparison of half-dose and standard-dose flupenthixol decanoate in the maintenance treatment of stabilised out-patients with schizophrenia.
    Johnson DA; Ludlow JM; Street K; Taylor RD
    Br J Psychiatry; 1987 Nov; 151():634-8. PubMed ID: 3446307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroral and parenteral administration of long-acting neuroleptics: a double-blind study of penfluridol compared to flupenthixol decanoate in the treatment of schizophrenia.
    Gerlach J; Kramp P; Kristjansen P; Lauritsen B; Lühdorf K; Munkvad I
    Acta Psychiatr Scand; 1975 Aug; 52(2):132-44. PubMed ID: 1096541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative trial of depot pipothiazine.
    Steinert J; Neder A; Erba E; Pugh CR; Robinson C; Priest RG
    J Int Med Res; 1986; 14(2):72-7. PubMed ID: 2870944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose flupenthixol decanoate in chronic schizophrenia.
    McCreadie RG; Flanagan WL; McKnight J; Jorgensen A
    Br J Psychiatry; 1979 Aug; 135():175-9. PubMed ID: 387151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perphenazine decanoate and cis(z)-flupentixol decanoate in maintenance treatment of schizophrenic outpatients. Serum levels at the minimum effective dose.
    Kistrup K; Gerlach J; Aaes-Jørgensen T; Larsen NE
    Psychopharmacology (Berl); 1991; 105(1):42-8. PubMed ID: 1745710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A depot neuroleptic withdrawal study. A controlled study of the clinical effects of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients.
    Wistedt B
    Acta Psychiatr Scand; 1981 Jul; 64(1):65-84. PubMed ID: 7032224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse effects of anticholinergic medication on positive schizophrenic symptoms.
    Johnstone EC; Crow TJ; Ferrier IN; Frith CD; Owens DG; Bourne RC; Gamble SJ
    Psychol Med; 1983 Aug; 13(3):513-27. PubMed ID: 6413994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative trial of the decanoates of flupenthixol and fluphenazine.
    Hamilton M; Card IR; Wallis GG; Mahmoud MR
    Psychopharmacology (Berl); 1979 Aug; 64(2):225-9. PubMed ID: 115046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flupenthixol decanoate and fluphenazine decanoate in chronic schizophrenia.
    Kong DS; Yeo SH
    Singapore Med J; 1985 Dec; 26(7):551-5. PubMed ID: 3834613
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum concentrations of cis(Z)-flupentixol and prolactin in chronic schizophrenic patients treated with flupentixol and cis(Z)-flupentixol decanoate.
    Jørgensen A; Andersen J; Bjørndal N; Dencker SJ; Lundin L; Malm U
    Psychopharmacology (Berl); 1982; 77(1):58-65. PubMed ID: 6812119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.